Home Applications 761420 Application 761420
Type BLA
Sponsor CELLTRION INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761420 Avtozma tocilizumab-anoh 351(k) Interchangeable Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AVTOZMA TOCILIZUMAB-ANOH INJECTABLE;INTRAVENOUS 80MG/4ML(20MG/ML) No No 002 AVTOZMA TOCILIZUMAB-ANOH INJECTABLE;INTRAVENOUS 200MG/10ML(20MG/ML) No No 003 AVTOZMA TOCILIZUMAB-ANOH INJECTABLE;INTRAVENOUS 400MG/20ML(20MG/ML) No No 004 AVTOZMA TOCILIZUMAB-ANOH INJECTABLE;SUBCUTANEOUS 162MG/0.9ML No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AVTOZMA TOCILIZUMAB CELLTRION USA, Inc. 581c288f-8015-40ef-a4c3-683c96db193d 2026-07-27 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761420
Documents# Document, Submission type, Date table Document Submission type Date 84784 SUPPL 2026-01-20 84757 SUPPL 2026-01-15 84269 ORIG 2025-11-24 83001 SUPPL 2025-07-31 82989 SUPPL 2025-07-30 82988 SUPPL 2025-07-30 81174 ORIG 2025-02-07 80894 ORIG 2025-02-04